Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TIA provides subsidized access to national translational research infrastructure for biologics, cell and gene therapies, small molecules, and RNA products. It accelerates the translation of discoveries from lab to clinic by supporting researchers with expertise and facilities across the full development pipeline. TIA does not have its own clinical results as it does not develop proprietary therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Therapeutic Innovation Australia.